A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
Los Angeles, CA · San Francisco, CA · +9 more sites
14 recruiting type 1 diabetes studies with a site in Los Angeles, CA.
Sponsor: City of Hope Medical Center
Los Angeles, CA · San Francisco, CA · +9 more sites
Sponsor: Oregon Health and Science University
Los Angeles, CA · +5 more sites
Sponsor: University of California, Los Angeles
Los Angeles, CA
Sponsor: Novo Nordisk A/S
Lancaster, CA · Lincoln, CA · Lomita, CA · +106 more sites
Sponsor: Mannkind Corporation
Los Angeles, CA · San Francisco, CA · +8 more sites
Sponsor: Insulet Corporation
Los Angeles, CA · Santa Barbara, CA · +9 more sites
Sponsor: University of California, San Francisco
Los Angeles, CA · San Diego, CA · San Francisco, CA
Sponsor: Zucara Therapeutics Inc.
Escondido, CA · Los Angeles, CA · San Carlos, CA · +35 more sites
Sponsor: Sanofi
Los Angeles, CA · San Francisco, CA · +35 more sites
Sponsor: Milton S. Hershey Medical Center
Los Angeles, CA · Stanford, CA · +10 more sites
Sponsor: Children's Hospital Los Angeles
Los Angeles, CA
Sponsor: Milton S. Hershey Medical Center
Los Angeles, CA · Stanford, CA · +10 more sites
Sponsor: Solstice Oncology, Inc.
Los Angeles, CA · +10 more sites
Sponsor: University of California, Los Angeles
Los Angeles, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.